Sangamo Biosciences Short Ratio

  

Short Ratio Analysis

Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Sangamo Biosciences 
Short Ratio 
 = 
Short Interest 
Average Trading Volume 
 = 
6.08 times

About Short Ratio

The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
Compare Sangamo Biosciences to competition

Sangamo Biosciences Short Ratio Assessment

Ratio  
Benchmark  Embed   Sangamo Biosciences Comparables 
Based on latest financial disclosure Sangamo Biosciences Inc has Short Ratio of 6.08 times. This is 35.41% higher than that of the Healthcare sector, and 34.51% higher than that of Biotechnology industry, The Short Ratio for all stocks is 220.0% lower than the firm.
ETFsFundsStocks

Filter other Stocks by Short Ratio

Short Ratio Input Range 
Industry  
Click to run this filter
Filter Other Equities
  
Found 10 equities

Short Ratio

GILD NMSGilead Sciences Inc
2.26 times
AMGN NMSAmgen Inc
2.45 times
CELG NMSCelgene Corporation
1.52 times
BIIB NMSBiogen Inc
1.74 times
REGN NMSRegeneron Pharmaceuticals Inc
4.26 times
ALXN NMSAlexion Pharmaceuticals Inc
4.15 times
BXLT NYQBaxalta Incorporated
1.97 times
VRTX NMSVertex Pharmaceuticals Incorporated
2.17 times
ILMN NMSIllumina Inc
4.25 times
BMRN NMSBioMarin Pharmaceutical Inc
3.81 times
You can backtest this sub-set of assets as a synthetic portfolio or check its risk adjusted returns  
Peer Comparison
Sangamo Biosciences Short Ratio Comparison
Short Ratio  
Benchmark  Embed   Sangamo Biosciences Comparables 
Sangamo Biosciences is currently under evaluation in short ratio category among related companies.
Return On Equity(14.99) %
Return On Asset(9.24) %
Profit Margin(68.35) %
Operating Margin(78.21) %
Current Valuation219.86 M
Shares Outstanding70.05 M
Shares Owned by Insiders4.18 %
Shares Owned by Institutions71.00 %
Number of Shares Shorted8.38 M
Price to Book2.19 times
Price to Sales9.83 times
Revenue45.37 M
Gross Profit45.87 M
EBITDA(34.59 M)
Net Income(31.01 M)
Cash and Equivalents219.33 M
Cash per Share3.13 times
Current Ratio10.29 times
Book Value Per Share2.91 times
Cash Flow from Operations(27.33 M)
Short Ratio6.08 times
One Year High19.25
One Year Low5.3
Earnings Per Share(0.45) times
Number of Employees102
Beta2.8
Market Capitalization439.19 M
Total Asset232.52 M
Retained Earnings(355.24 M)
Working Capital119.14 M
Current Asset227.68 M
Current Liabilities22.13 M
Z Score-1.4